Illumina INC:1107104 [22-003899] 01-novaseq 6000 S4 reagent kit V1.5(200 cycles) 02-novaseq XP 2-lane kit V1.5 03-novaseq 6000 SP reagent kit V1.5(300 cycles) 04-novaseq 6000 S1 reagent kit V1.5(100…
Ended Awarded
- Contract number
- 75N92B22F20008
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $90,413
Award facts
- Contract value 100% obligated
- $90,412.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
This firm fixed-price delivery order was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc. for the purchase of various NovaSeq 6000 sequencing system reagent kits and accessories. The total ceiling value of the contract is $90,412.75 and it has an ultimate completion date of September 2, 2025. This award is not associated with a set-aside program. Illumina has previously held prime federal contracts and subcontracts with other agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs to provide genomic sequencing instruments, reagents, and related services. The NovaSeq 6000 platform is a high-throughput sequencing system used for life science research, applied markets, and molecular diagnostics applications.
Description
Illumina INC:1107104 [22-003899] 01-novaseq 6000 S4 reagent kit V1.5(200 cycles) 02-novaseq XP 2-lane kit V1.5 03-novaseq 6000 SP reagent kit V1.5(300 cycles) 04-novaseq 6000 S1 reagent kit V1.5(100 cycles) 05-novaseq 6000 S1 reagent kit V1.5(20
Quick answers
Who was awarded contract 75N92B22F20008?
75N92B22F20008 was awarded to Illumina, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on August 12, 2022.
How much is contract 75N92B22F20008 worth?
The government has obligated $90,413 on 75N92B22F20008.
Is contract 75N92B22F20008 an order under another contract?
Yes. 75N92B22F20008 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92B22F20008 competed?
The extent of competition for 75N92B22F20008 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award